rnl bio News

Two autologous stem cell therapy sessions prevented patient from foot amputation

-Electromyogram (EMG) findings show improvement in conduction speed and latency -RNL Bio’s stem cell therapy demonstrates effective outcomes

Patient’s own fat-derived stem cell cured severe atopic syndrome

RNL Bio successfully cloned a small breed Pekingese commercially for the first time in the world.

As a promotion from RNL Bio, pet owners who register RNL's stem cell bank for animals will have unique opportunity for free stem cell therapy for their pets.

RNL Bio successfully treated a horse with syndesmitis and it will return to race track soon.

RNL Bio made another breakthrough in dog cloning history. Two clones were born from a Beagle donor's stem cells instead of skin cells.

Intravenous delivery of adipose derived stem cells showed effects on liver function restoration

The world's first commercially cloned dogs were sent home last month. The company recommends pet owners to be prepared for dogs' sudden death by saving live cells while they are alive.

RNL's stem cell clinic is specialized in cell therapies for degenerative diseases and anti-aging treatments using intravenous injections of stem cells and accepting patients from North America and Europe.

RNL Bio offers an exceptional promotion for dog cloning at hugely discounted cost.

- Five clones from ‘Booger’ were born by world’s first commercial order. - The project completed in only 70 days, boasting the efficacy of the technology. - RNL starts to offer cloning service, world-wide.

The world's first drug-sniffing canine clones were qualified for the evaluation of the good qualities in qualification test.

The dead pet dog's cells were arrived in Seoul Korea for the world's fisrt commercial dog cloning project.